Vectopia raises CHF 50,000

Vectopia, a University of Geneva spin-off, develops a new production method for lentiviral vectors used in gene therapy. The project receives a CHF 50,000 FIF Grant to move towards market.

Announced on
Round
Grant
Amount
CHF 50,000
Location
Geneva
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic